Net delta exposure for Bristol-Myers Squibb Co (BMY) options was $465.3M per 1% move at the Nov 4, 2026 close. It has been positive on 14 of the last 20 trading days. Four weeks earlier, on Oct 7, 2026, it was -$26.84M.
Upgrade to unlock Call Wall, Put Wall, and multiple expiration dates.
Delta Exposure by Strike
Showing results for BMY, 2026-11-06(w), calls & puts
Delta Exposure Stats
Showing results for BMY, 2026-11-06(w), calls & puts
Net Delta Exposure by Expiration
Showing results for BMY, 2026-11-06(w), calls & puts. View all expiries
| Expiration | Net DEX | Call DEX | Put DEX | Call Wall | Put Wall |
|---|
BMY Delta Exposure FAQ
What is delta exposure (DEX)?
Delta exposure estimates the dollar value of shares option dealers hold or owe as a hedge, per 1% move in the underlying.
Is BMY delta exposure positive or negative?
Bristol-Myers Squibb net delta exposure was positive on Nov 4, 2026, at $465.3M. It has been positive on 14 of the last 20 trading days.
How has BMY delta exposure changed recently?
Bristol-Myers Squibb net delta exposure went from -$26.84M on Oct 7, 2026 to $465.3M on Nov 4, 2026. See the BMY delta exposure history for a longer view.
What is Bristol-Myers Squibb Co?
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders.